NHS National Stroke Director Interview

New Webinar - Expanding Thrombectomy Access: Real-World Evaluation of Stroke AI Imaging Across a Network.     Register here »

AI Innovators with Global Expertise

Since launching as a spin-out from the University of Oxford, Brainomix has pioneered the development of an AI platform that automates validated imaging biomarkers to improve both diagnosis and treatment decisions.

Our Brainomix 360 Stroke platform is the world's most comprehensive stroke imaging solution, widely adopted across multiple healthcare systems worldwide.

Building on this legacy and success, we are expanding beyond stroke into new areas, where there are similar unmet needs and opportunities to improve diagnosis and treatment.

Global Expertise
Stroke

Stroke

Brainomix has developed the world's first, and most advanced, fully automated AI-imaging solution for stroke assessment.

With applications to support all your simple and advanced imaging requirements, our e-Stroke platform can enhance the decision-making and care that you provide at your institution.

Learn more
ILD

ILD

Brainomix's automated AI-imaging solution for Interstitial Lung Disease (ILD) assessment features a variety of classifiers and biomarkers for use in clinical trials.

Find out how we can support your clinical development for treatments such as ILD, IPF and other lung diseases by improving patient selection and efficacy assessment.

Learn more
Cancer

Cancer

Brainomix's automated AI-imaging solution for solid tumor assessment features a variety of classifiers and biomarkers for use in clinical trials.

Find out how we can support your clinical development for treatments such as NSCLC, and other solid-tumors by improving patient selection and efficacy assessment.

Learn more

Value-Generating Partnerships

Over the years, Brainomix has formed a number of key partnerships that have enabled us to broaden our reach, expand our portfolio, and deliver innovative, end-to-end solutions to customers.

Learn more about our focus on creating value-generating partnerships that can improve clinical trial success and foster broad adoption of existing therapies in stroke, lung fibrosis and cancer.

Partnership Wide

Expanding Access to Life-Saving Treatments

At Brainomix, we are committed to developing innovative AI solutions that will improve patient outcomes.

Take a moment to learn about Margaret's story, a patient from Milton Keynes who suffered a stroke, but who was quickly diagnosed, transferred and treated - all with the help of Brainomix's technology.

Our Partners

Leave Your Legacy Portuguese Logo
Stryker
OSIC Logo
Boehringer Ingelheim Logo
Nvidia Logo
NCIMI Logo
GE Healthcare
Wallaby Logo
TCPDS MEMBER BLACK
Oxlep ERDF BW
Blackford
Fora Logo